That online ‘pharmacy’ could kill you, feds warn

US Drug Enforcement Administration investigators warn about a rise in illegal, typically foreign-based online stores that are allegedly targeting American consumers with deceptive practices. Read More

US FDA to reconsider decision barring compounded versions of Lilly weight loss drug

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes ... Read More

Lexington biotech resubmits dry eye drug for FDA approval a year after rejection

Lexington biotech Aldeyra is trying once again to win approval for its dry eye disease drug, called reproxalap, after an FDA rejection last year. Read More

US releases preliminary list of $2 generic drugs for Medicare recipients

The U.S. Centers for Medicare & Medicaid Services released on Wednesday a preliminary list of 101 generic drugs that would be available for no more than $2 for a month's supply to those enrolled in ... Read More

FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening

Pressure is mounting in Congress and the regulatory agencies for changes to the drug patent system. Time will tell how fast such reform will come about. Read More